These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 6231980)

  • 21. Interaction of monoclonal antibodies with the IgE-receptor on rat mast cells and rat basophilic leukemia (RBL) cells.
    Micklefield G; König W; Pfeiffer P; Bohn A
    Agents Actions; 1986 Mar; 17(5-6):418-26. PubMed ID: 2422899
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modulation of immunoglobulin (Ig)E-mediated systemic anaphylaxis by low-affinity Fc receptors for IgG.
    Ujike A; Ishikawa Y; Ono M; Yuasa T; Yoshino T; Fukumoto M; Ravetch JV; Takai T
    J Exp Med; 1999 May; 189(10):1573-9. PubMed ID: 10330436
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IgE and mechanisms of IgE-mediated hypersensitivity.
    Ishizaka T
    Ann Allergy; 1982 Jun; 48(6):313-9. PubMed ID: 6178321
    [No Abstract]   [Full Text] [Related]  

  • 24. IgG4 and passive sensitization of basophil leukocytes.
    van Toorenenbergen AW; Aalberse RC
    Int Arch Allergy Appl Immunol; 1981; 65(4):432-40. PubMed ID: 6166572
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mast cell membrane antigens and Fc receptors in anaphylaxis. II. Functionally distinct receptors for IgG and for IgE on mouse mast cells.
    Daëron M; Prouvost-Danon A; Voisin GA
    Cell Immunol; 1980 Jan; 49(1):178-89. PubMed ID: 7351030
    [No Abstract]   [Full Text] [Related]  

  • 26. Study of complement-mediated anaphylaxis in humans. The role of IgG subclasses (IgG1 and/or IgG4) in the complement-activating capacity of immune complexes.
    Bergamaschini L; Santangelo T; Faricciotti A; Ciavarella N; Mannucci PM; Agostoni A
    J Immunol; 1996 Feb; 156(3):1256-61. PubMed ID: 8558005
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of IgG subclass-specific anti-IgE antibodies in normal and atopic individuals.
    Wilson PB; Fairfield JE; Beech N
    Int Arch Allergy Appl Immunol; 1987; 84(2):198-204. PubMed ID: 3498693
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nonreaginic anaphylactic antibodies in man.
    Goodwin BF
    Clin Rev Allergy; 1983 Jun; 1(2):249-58. PubMed ID: 6231982
    [No Abstract]   [Full Text] [Related]  

  • 29. Anaphylactic transfusion reactions in haptoglobin-deficient patients with IgE and IgG haptoglobin antibodies.
    Shimada E; Tadokoro K; Watanabe Y; Ikeda K; Niihara H; Maeda I; Isa K; Moriya S; Ashida T; Mitsunaga S; Nakajima K; Juji T
    Transfusion; 2002 Jun; 42(6):766-73. PubMed ID: 12147031
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Macrophages are the dominant effector cells responsible for IgG-mediated passive systemic anaphylaxis challenged by natural protein antigen in BALB/c and C57BL/6 mice.
    Jiao D; Liu Y; Lu X; Liu B; Pan Q; Liu Y; Liu Y; Zhu P; Fu N
    Cell Immunol; 2014; 289(1-2):97-105. PubMed ID: 24751884
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nonreaginic anaphylactic and/or blocking antibodies: conclusion.
    Halpern GM
    Clin Rev Allergy; 1983 Jun; 1(2):303-8. PubMed ID: 6673824
    [No Abstract]   [Full Text] [Related]  

  • 32. Pathophysiology of anaphylaxis.
    Khan BQ; Kemp SF
    Curr Opin Allergy Clin Immunol; 2011 Aug; 11(4):319-25. PubMed ID: 21659865
    [TBL] [Abstract][Full Text] [Related]  

  • 33. State--and dynamics--of the art: a current review. IgE-mediated immediate hypersensitivity reactions: cellular events and pharmacologic mediators.
    Haddad ZH; Green A
    J Asthma; 1983; 20(3):197-214. PubMed ID: 6190793
    [No Abstract]   [Full Text] [Related]  

  • 34. The molecular pathology of IgG4.
    Stanworth DR
    Monogr Allergy; 1986; 19():227-40. PubMed ID: 3762550
    [No Abstract]   [Full Text] [Related]  

  • 35. [Cellular mechanisms of anaphylaxis].
    Gushchin IS
    Patol Fiziol Eksp Ter; 1973; 17(5):3-15. PubMed ID: 4133210
    [No Abstract]   [Full Text] [Related]  

  • 36. Smooth muscle contraction and release of histamine and slow-reacting substance of anaphylaxis in pulmonary tissues isolated from guinea pigs passively sensitized with IgG1 or IgE antibodies.
    Undem BJ; Buckner CK; Harley P; Graziano FM
    Am Rev Respir Dis; 1985 Feb; 131(2):260-6. PubMed ID: 2578761
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IgG4: characteristics and its role in allergic diseases.
    Gamboa PM; Tabar A; Wong E; Oehling A
    Allergol Immunopathol (Madr); 1986; 14(2):155-63. PubMed ID: 2940847
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Absence of Fc epsilonRI alpha chain results in upregulation of Fc gammaRIII-dependent mast cell degranulation and anaphylaxis. Evidence of competition between Fc epsilonRI and Fc gammaRIII for limiting amounts of FcR beta and gamma chains.
    Dombrowicz D; Flamand V; Miyajima I; Ravetch JV; Galli SJ; Kinet JP
    J Clin Invest; 1997 Mar; 99(5):915-25. PubMed ID: 9062349
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo arming of cutaneous mast cell receptors by IgE released from macrophages.
    Holt PG; Bilyk N; Vines J; Turner KJ; Thomas WR
    Int Arch Allergy Appl Immunol; 1989; 89(4):381-6. PubMed ID: 2793224
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ten Weeks of Infection with a Tissue-Invasive Helminth Protects against Local Immune Complex-Mediated Inflammation, but Not Cutaneous Type I Hypersensitivity, in Previously Sensitized Mice.
    Evans H; Killoran KE; Mitre BK; Morris CP; Kim SY; Mitre E
    J Immunol; 2015 Oct; 195(7):2973-84. PubMed ID: 26324775
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.